Global Cardio Vascular Market Review

Global Cardio Vascular Market Review
of 160
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
   1 The Cardiovascular Market Outlook to 2016 Competitive landscape, global market analysis, key trends, and pipeline analysis Reference Code: BI00042-007 Publication Date: June 2011   2 About Business Insights Business Insights has a team of in-house pharmaceutical and regulatory analysts drawn from consulting, R&D and competitive intelligence life sciences backgrounds. Our analysts specialize in providing detailed insight into the future of therapeutic drug markets and emerging pharmaceutical markets and have extensive analytical, forecasting and research experience in the pharmaceutical, biotech and outsourcing sectors. Our team maintains regular contact with industry executives to track market developments and base their market models on a wide range of proprietary drug sales, pipeline and epidemiological databases to provide up to date, accurate strategic insight on the future of the pharmaceutical market. Disclaimer Copyright © 2011 Business Insights Ltd This report is published by Business Insights (the Publisher). This report contains information from reputable sources and although reasonable efforts have been made to publish accurate information, you assume sole responsibility for the selection, suitability and use of this report and acknowledge that the Publisher makes no warranties (either express or implied) as to, nor accepts liability for, the accuracy or fitness for a particular purpose of the information or advice contained herein. The Publisher wishes to make it clear that any views or opinions expressed in this report by individual authors or contributors are their personal views and opinions and do not necessarily reflect the views/opinions of the Publisher.   3 Table of Contents About Business Insights 2   Disclaimer 2   Executive Summary 13   Overview and epidemiology of cardiovascular disorders 13   Global market analysis 13   Pipeline analysis 14   Competitive landscape 15   Chapter 1 Overview and epidemiology of cardiovascular disorders 17   Summary 17   Introduction 17   Risk factors 18   Predisposing risk factors 18   Modifiable risk factors 21   Hypertension 21   Diagnosis, treatment and management 22   Epidemiology 24   Forecast epidemiology 26   Dyslipidemia 27   Diagnosis, treatment, and management 29   Epidemiology 30   Forecast epidemiology 31   Cardiovascular diseases 33   Arteriosclerosis/atherosclerosis 33     4 Thrombosis 33   Cardiac arrhythmias 33   Myocardial infarction (MI) 33   Acute coronary syndrome (ACS) 34   Congestive heart failure (CHF) 34   Coronary artery disease (CAD) 34   Peripheral artery disease (PAD) 34   Pulmonary hypertension 34   Angina pectoris 35   Stroke 35   Epidemiology 35   Forecast epidemiology 36   Chapter 2 Global market analysis 38   Summary 38   Introduction 39   Market analysis by geography 40   Key events in the cardiovascular market 41   European approval for Rasilamlo 41   BMS/Pfizer’s apixaban likely to receive EU approval 41   Angiotensin receptor blockers (ARBs) may cause increased cancer risk 42   Crestor’s patent upheld in the US 43   Plavix boxed warning for poor metabolizers 43   Market analysis by drug class 44   Antihypertensives 46   Introduction 46   Antihypertensive drug classes 46   Leading treatment brands by drug class 47  
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks